Use of Inhaled Corticosteroids and Healthcare Costs in Mild Persistent Asthma

References

• Irani A M. The challenge of mild persistent asthma. Ann Allergy Asthma Immunol 2005; 94: 517–527
   PubMedGoogle Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention. National Heart, Lung and Blood Institute, National Institutes of Health. 2002, Publication 02-3659; Updated 2004 from the original document.
   Google Scholar
• National Asthma Education and Prevention Program. Expert panel report 2: Guidelines for the diagnosis and management of asthma. National, Heart, Lung and Blood Institute, National Institutes of Health. July, 1997, Publication 97-4051
   Google Scholar
• National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma National, Heart, Lung and Blood Institute. National Institutes of Health. J Allergy Clin Immunol 2002; 110: 141–219
   PubMedGoogle Scholar
• O'Byrne P M, Barnes P J, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, Tattersfield A. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 2001; 164: 1392–1397
   PubMed Web of Science ®Google Scholar
• Pauwels R A, Pedersen S, Busse W W, et al. Early intervention with budesonide in mild persistent asthma. Lancet 2003; 361: 1071–1076
   PubMed Web of Science ®Google Scholar
• Sin D D, Man S FP. Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch Intern Med 2002; 162: 1591–1595
   PubMed Web of Science ®Google Scholar
• Suissa S, Ernst P. Inhaled corticosteroids: Impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001; 107: 937–944
   PubMed Web of Science ®Google Scholar
• Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000; 343: 332–336
   PubMed Web of Science ®Google Scholar
• Boushey H A, Sorkness C A, King T S, Sullivan S D, Fahy J V, Lazarus S C, Chinchilli V M, Craig T J, Dimango E A, Deykin A, Fagan J K, Fish J E, Ford J G, Kraft M, Lemanske R F, Leone F T, Martin R J, Mauger E A, Pesola G R, Peters S P, Rollings N J, Szefler S J, Wechsler M E, Israel E, National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 2005; 352: 1519–1528
   PubMed Web of Science ®Google Scholar
• Colice G, Wu E Q, Bimbaum H, Daher M, Marynchenko M B, Varghese S. Healthcare and work loss costs associated with persistent asthma patients in a privately insured population. J Occup Environ Med 2006; 48: 794–802
   PubMed Web of Science ®Google Scholar
• Friedman H S, Yawn B P. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids. Curr Med Res Opin 2007; 23: 427–434
   PubMed Web of Science ®Google Scholar
• National Committee for Quality Assurance. Use of appropriate medications for people with asthma. Washington, DC, HEDIS 2005, Vol 2. Technical Specifications
   Google Scholar
• Leidy N K, Paramore L C, Watrous M, Doyle J, Zeiger R S. Development of an algorithm for estimating asthma severity from an administrative cost database. Value Health 1999; 2: 394
   Google Scholar
• Little R, Rubin D. Statistical Analysis with Missing Data. John Wiley & Sons, New York, NY 1987; 62–67
   Google Scholar
• Weiss K B, Sullivan S D. The health economics of asthma and rhinitis. J Allergy Clin Immunol 2001; 107: 3–8
   PubMed Web of Science ®Google Scholar
• Cisternas M G, Blanc P D, Yen I H, Katz P P, Earnest G, Eisner M D, Shiboski S, Yelin E H. A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol 2003; 111: 1203–1204
   PubMedGoogle Scholar
• Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G. Costs of asthma are correlated with severity. Eur Respir J 2002; 19: 61–67
   PubMed Web of Science ®Google Scholar
• Serra-Batlles J, Plaza V, Morejon E, Comella A, Brugues J. Costs of asthma according to the degree of severity. Eur Respir J 1998; 12: 1322–1326
   PubMed Web of Science ®Google Scholar
• O'Byrne P, Cuddy L, Taylor D W, Birch S, Morris J, Syrotuik J. Efficacy and cost benefit of inhaled corticosteroids in patients considered to have mild asthma in primary care practice. Can Respir J 1996; 3: 169–175
   Google Scholar
• Sullivan S D, Buxton M, Andersson L F, Lamm C J, Liljas B, Chen Y Z, Pauwels R A, Weiss K B. Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol 2003; 112: 1229–1236
   PubMed Web of Science ®Google Scholar
• Cochrane M G, Bala M V, Downs K E, Mauskopf J, Ben-Joseph R H. Inhaled corticosteroids for asthma therapy; patient compliance, devices and inhalation technique. Chest 2000; 117: 542–550
   PubMed Web of Science ®Google Scholar
• Wolfenden L L, Diette G B, Krishnan J A, Skinner E A, Steinwachs D M, Wu A W. Lower physician estimate of underlying asthma severity leads to undertreatment. Arch Intern Med 2003; 163: 231–236
   PubMed Web of Science ®Google Scholar
• Schatz M, Zelger R S, Vollmer W M, Mosen D, Apter A J, Stibolt T B, Leong A, Johnson M S, Mendoza G, Cook E F. Validation of a β-agonist long-term asthma control scale derived from computerized pharmacy data. J Allergy Clin Immunol 2006; 117: 995–1000
   PubMed Web of Science ®Google Scholar
• Fuhlbrigge A L, Carey V J, Finkelstein J A, Lozano P, Inui T S, Weiss S T, Weiss K B. Validity of the HEDIS criteria to identify children with persistent asthma and sustained high utilization. Am J Manag Care 2005; 11: 325–330
   PubMedGoogle Scholar
• Mosen D M, Macy E, Schatz M, Mendoza G, Stibolt T B, McGaw J, Goldstein J, Bellows J. How well do the HEDIS asthma inclusion criteria identify persistent asthma. Am J Manag Care 2005; 11: 650–654
   PubMedGoogle Scholar
• Cabana M D, Slish K K, Nan B, Clark N M. Limits of the HEDIS criteria in determining asthma severity for children. Pediatrics 2004; 114: 1049–1055
   PubMed Web of Science ®Google Scholar
• Berger W E, Legorreta A P, Blaiss M S, Schneider E C, Luskin A T, Stempel D A, Suissa S, Goodman D C, Stoloff S W, Chapman J A, Sullivan S D, Vollmer B, Weiss K B. The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. Ann Allergy Asthma Immunol 2004; 93: 538–545
   PubMed Web of Science ®Google Scholar